ENISOPROST manufacturers
- SC 34301
-
- $3400.00
-
2026-05-11
- CAS:81026-63-3
- Purity:
- Supply Ability: 10g
|
| | ENISOPROST Basic information |
| Product Name: | ENISOPROST | | Synonyms: | SC-34301;ENISOPROST;Prosta-4,13-dien-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (4Z,11alpha,13E)-(+-)-;Prosta-4,13-dien-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (4Z,11α,13E)-(±)- | | CAS: | 81026-63-3 | | MF: | C22H36O5 | | MW: | 380.52 | | EINECS: | | | Product Categories: | | | Mol File: | 81026-63-3.mol |  |
| | ENISOPROST Chemical Properties |
| Boiling point | 490.2±45.0 °C(Predicted) | | density | 1.092±0.06 g/cm3(Predicted) | | pka | 13.90±0.60(Predicted) |
| | ENISOPROST Usage And Synthesis |
| Uses | Anti-ulcerative. | | Uses | Enisoprost is the antisecretory prostaglandin derivative. Analogue of Prostaglandin E1 (P838600), which is the primary prostaglandin that is easily crystallized from purified biological extracts. | | in vivo | SC 34301 (200 μg/kg; p.o.; once a day for three days) significantly reduces bacterial translocation and improves survival[1]. | Animal Model: | BALB/c mice (E. coli, burned)[1] | | Dosage: | 200 μg/kg | | Administration: | P.o.; once a day for three days | | Result: | Significantly reduced the degree of bacterial translocation as measured by blood dpm counts, improved survival rate to 60% in burned mice. |
|
| | ENISOPROST Preparation Products And Raw materials |
|